Log In
Print this Print this

Neihulizumab (AbGn-168H) (formerly AbGn-168)

  Manage Alerts
Collapse Summary General Information
Company AbGenomics International Inc.
DescriptionHuman mAb against P selectin glycoprotein ligand-1 (PSGL-1; CD162; SELPLG)
Molecular Target P selectin glycoprotein ligand-1 (PSGL-1) (CD162) (SELPLG)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today